Science

Barbara Bush

Barbara Bush’s End-Of-Life Decision Stirs Debate Over ‘Comfort Care’

TEXAS—(ENEWSPF)—April 19, 2018 By: Melissa Bailey and JoNel Aleccia Former first lady Barbara Bush died Tuesday night at her home in Houston at age 92. Days before her death, the announcement that she was seeking “comfort care” shone a light — and stirred debate — on what it means to stop[Read More…]

Epstein-Barr virus

Epstein-Barr Virus Protein Can “Switch On” Risk Genes for Autoimmune Diseases

EBV may trigger some cases of lupus, say NIH-supported researchers. Bethesda, Maryland—(ENEWSPF)—April 16, 2018 Contact: Judith Lavelle Infection with Epstein-Barr virus (EBV), the cause of infectious mononucleosis, has been associated with subsequent development of systemic lupus erythematosus and other chronic autoimmune illnesses, but the mechanisms behind this association have been[Read More…]

Bullying

Cyberbullying, Unmet Medical Needs Contribute to Depressive Symptoms Among Sexual Minority Youth

NIH study finds higher rates of dissatisfaction with family relationships. Bethesda, Maryland—(ENEWSPF)—April 16, 2018 Contact: Meredith Daly and Robert Bock Cyberbullying, dissatisfaction with family relationships, and unmet medical needs are major contributors to the high rates of depressive symptoms seen among adolescents who are gay, lesbian, bisexual or questioning their[Read More…]

FDA

FDA Takes Step to Protect Consumers Against Dietary Supplements Containing Dangerously High Levels of Pure Caffeine

Silver Spring, Maryland—(ENEWSPF)—April 13, 2018 Contact: Theresa Eisenman Today, the U.S. Food and Drug Administration took an important step to better protect consumers from the dangers of highly concentrated and pure caffeine products. These products present a significant public health threat because of the high risk that they will be[Read More…]

IDx-DR for diabetic retinopothy

FDA Permits Marketing of Device to Detect Certain Diabetes-related Eye Problems

Silver Spring, Maryland—(ENEWSPF)—April 12, 2018 By: Angela Stark The U.S. Food and Drug Administration (FDA) permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. Diabetic retinopathy occurs when high levels[Read More…]

Most read stories this week

Take a Survey

ARCHIVES